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Letter to the Editors
Alzheimer's Disease and
Aluminum Toxicology
Dear Editors:
Arecent paperby C. N. Martynandcolleagues (1) appears
to reinforce the environmental dismetabolic aluminumhypo-
thesis of McLaclan (2), i.e., the involvement of abnormal
aluminum (III) accumulation in the brain in the etiology of
Alzheimer's disease (AD). Another recentreviewbyDeary
andWhelley (3) remarkably presents AD as apeculiar syn-
drome, which may represent the final result of diverse
etiological factors.
The essential, only postmortem determined features of
AD are a) senile plaques (i.e, neuronal degeneration areas,
mainly of the cortex and hippocampus); b) neurofibrillary
degeneration (proliferation of regular helix-shaped pairs of
neurofilaments 10 nm in diameter, helically wound around
eachotherwithperiodictwists 80 nmapart); andc) reduction
of neurotransmitter activity, especially in the cholinergic
system. Literature dataand work carried outinthese labora-
tories lend credit to the possible involvement of aluminum
(III) in all three hallmarks of AD.
Senile Plaques
Itis known thathippocampal membrane alterations occur
inAD-affected patients (4), and it appears possible that the
formation ofsenile plaques mayjust start with the degrada-
tion of the neuronal plasmatic membrane (5). In this con-
nection, aluminum (III) may play a role by promoting mem-
brane lipids peroxidation (6,7). Moreover, we find that the
hydrolytically stable complex Al (acac)3 (acac = 2,4-pen-
tanedionate) is an effective chemical aggressor to the mem-
brane ofrabbit and rat erythrocytes (8,9), in that it causes
osmotic fragility, extensive morphological defects (acanthocy-
tosis), and a strong decrease in membrane fluidity (9).
Human erythrocytes seem tobe more resistant to aluminum
(III), which causes, however, a significant modification in
the membrane's protein configurations (9).
Neurofibrillary Degeneration
Many experiments in vivo based on the administration
ofA1(III) solution (10) succeeded in producing in the rabbit
the proliferation of disorganized tangles of 10-nm diameter
filaments, whose ultrastructure is similar to that ofnormal
neurofilaments and whose pattern ofimmunocytochemical
stainingis similar to the pattern observed inAD (11). These
observations are remarkable in that, on the one side, they
lend credit to the supporters ofthe dismetabolic aluminum
hypothesis, and on the other side, the specific morphologic
features of the Al(III)-induced neurofibrillary degeneration
were used by the opposers to the hypothesis for stressing
that the nonhelix andnonpaired nature ofthe neurofilaments
is a strong indication against any connection between an
effect of Al(III) and AD.
In view of the great complexity of aqueous solution of
Al(III) at pH 7.5 in the absence of strongly coordinating
ligands (12), it has to be pointed out that all the experiments
giving rise to anomalous neurofibrillary degeneration are
based, in fact, on the administration ofvery poorly defined
metal toxins. In this connection, toxicological experimenta-
tion in vivo and in vitro carried out in these laboratories
is giving ample evidence that the speciation of the metal
center is a crucial feature in directing the type oftoxic effect
of A1(II1). Thus, Al(acac)3 [neutral, octahedral, hydrolytic-
ally stable, and lipophilic (13)] and Al(malt)3 (malt =
2-methyl-3-hydroxy4-pironate) [neutral, octahedral, hydro-
lytically stable, and hydrophilic (13)] exhibit quite different
toxicological behaviors (14), and they both behave quite dif-
ferently with respect to aqueous aluminumlactate, for exam-
ple, in their action on murine neuroblastomas (15).
It appears quite possible thatthe inability ofAl(III) admin-
istration in inducing helixlike paired neurofilaments identical
to those observed in AD may be the consequence ofspecia-
tion effects and that a more tailored and appropriate choice
ofthe coordination sphere ofthe metal toxin may eventually
lead to the production ofneurofibrillarytangles quite similar
to those typical of AD.
Reduction of Neurotransmitter Activity
Postmortem neurochemical studies on AD patients dem-
onstrated a severe loss of cortical neurotransmitters, par-
ticularly in the cholinergic synthetic enzymes activities (16)
and to a lesser extent in several other cortical neurotrans-
mitters systems such as somatostatinergic (17), serotonin-
ergic (18), andnoradrenergic (1) neurotransmitters. Inmodel
experiments, it was found that Al(III) inhibits choline
transport in rat brain (20), in rat synaptosomes from cortex
andhippocampus (21), and in humanerythrocytes (22) and
reduced neuralcholine acetyltransferase activityinthe rabbit
(23). The uptake ofcholine, glutamate, norepinephrine, and
serotonininto rat synaposomes was also found tobe inhibited
byA1(III) (20,24,25). Moreover, inview ofthe criticalrele-
vance ofthe fluidity ofneuronalmembranes to the correct
functioningofmembrane receptors [especiallythose relevant234 CORAIN ET AL.
to serotonin (26)], it is possible that the influence ofAl(III)
on this cellular feature could eventuallyjoin two aspects of
aluminum pathology, i.e, aggression to the plasmatic mem-
brane and reduction of neurotransmitter activity.
In conclusion, we would like to stress the importance of
thinking in terms ofAI(III) speciation in biological, biochem-
ical, andbioinorganic research. Thus, future experimentation
shouldtake in account a) the hydrolytic behavior ofthe metal
center; b) the existence in solution of natural or artificial
(designed) complexing agent; c) the thermodynamic stability
and the kinetic behavior (lability-inertia) ofthe relevant ad-
ducts; d) the analytical concentration of both metal and
ligands; and e) the lipophilic-hydrophilic character of the
administered species.
Summary
The three hallmarks ofAlzheimer's disease, i.e., senile
plaques, neurofibrillary degeneration, and reduction in
cholinergic activity, are evaluated as possible results ofthe
aggression of dismetabolic A1(III) to relevant biological
targets. Recentbiologicalexperimentation in viw and in vitro
supports such connection and stresses the dramatic impor-
tance ofmetal speciation in directing the pathological effects
Al(III).
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